XML 34 R14.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Accrued and Other Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2016
Payables and Accruals [Abstract] |
Accrued and Other Liabilities | 6. ACCRUED AND OTHER LIABILITIES Accrued liabilities and other liabilities consist of the following (in thousands):
|  | December 31, |
|  | 2016 |  |  | 2015 |
Accrued clinical trial expenses |  | $ | 6,694 |  |  | $ | 311 |
Accrued contract manufacturing |  |  | 2,705 |  |  |  | 289 |
Accrued professional and consulting services |  |  | 322 |  |  |  | 272 |
AstraZeneca clinical trial material accrual |  |  | — |  |  |  | 1,328 |
Other |  |  | 684 |  |  |  | 380 |
|  | $ | 10,405 |  |  | $ | 2,580 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration